Movement Alert｜Eli Lilly Rises 3.08% in Pre-Market Trading, Multiple Banks Raise Target Prices as Mounjaro Gains Pediatric Approval in Canada

Market Focus

Jul 07

On July 7, Eli Lilly rose 3.08% in pre-market trading, trading at $1,235.0/share, with turnover of $22.23 million.

On the news front, JPMorgan raised its target price on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from the current level. Analyst Chris Schott expects total quarterly sales of approximately $20.7 billion and EPS of $8.85, both above consensus estimates, driven by Mounjaro's continued international volume growth and steady U.S. obesity market expansion. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.

Additionally, Health Canada approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in pediatric patients aged 10 and older, further broadening the drug's addressable population. The company's next earnings report is scheduled for August 5, with consensus EPS expected at $8.98.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1141456507"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141456507\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141456507?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 21:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141456507","market":"us","top_or_hot":-1,"title":"Movement Alert｜Eli Lilly Rises 3.08% in Pre-Market Trading, Multiple Banks Raise Target Prices as Mounjaro Gains Pediatric Approval in Canada","media":"Market Focus","content":"<p><p>On July 7, Eli Lilly rose 3.08% in pre-market trading, trading at $1,235.0/share, with turnover of $22.23 million.</p><p>On the news front, JPMorgan raised its target price on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from the current level. Analyst Chris Schott expects total quarterly sales of approximately $20.7 billion and EPS of $8.85, both above consensus estimates, driven by Mounjaro's continued international volume growth and steady U.S. obesity market expansion. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.</p><p>Additionally, Health Canada approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in pediatric patients aged 10 and older, further broadening the drug's addressable population. The company's next earnings report is scheduled for August 5, with consensus EPS expected at $8.98.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Eli Lilly Rises 3.08% in Pre-Market Trading, Multiple Banks Raise Target Prices as Mounjaro Gains Pediatric Approval in Canada</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Eli Lilly Rises 3.08% in Pre-Market Trading, Multiple Banks Raise Target Prices as Mounjaro Gains Pediatric Approval in Canada\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 21:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, Eli Lilly rose 3.08% in pre-market trading, trading at $1,235.0/share, with turnover of $22.23 million.</p><p>On the news front, JPMorgan raised its target price on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from the current level. Analyst Chris Schott expects total quarterly sales of approximately $20.7 billion and EPS of $8.85, both above consensus estimates, driven by Mounjaro's continued international volume growth and steady U.S. obesity market expansion. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.</p><p>Additionally, Health Canada approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in pediatric patients aged 10 and older, further broadening the drug's addressable population. The company's next earnings report is scheduled for August 5, with consensus EPS expected at $8.98.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"","article_id":"1141456507","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141456507","pubTimestamp":1783430829,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, Eli Lilly rose 3.08% in pre-market trading, trading at $1,235.0/share, with turnover of $22.23 million.On the news front, JPMorgan raised its target price on Eli Lilly from $1,300 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"动向提示|礼来盘前涨3.08%Mounjaro获加拿大儿科批准多家银行上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"On July 7, Eli Lilly rose 3.08% in pre-market trading, trading at $1,235.0/share, with turnover of $22.23 million.On the news front, JPMorgan raised its target price on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from the current level. Analyst Chris Schott expects total quarterly sales of approximately $20.7 billion and EPS of $8.85, both above consensus estimates, driven by Mounjaro's continued international volume growth and steady U.S. obesity market expansion. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.Additionally, Health Canada approved Mounjaro (tirzepatide) for the treatment of type 2 diabetes in pediatric patients aged 10 and older, further broadening the drug's addressable population. The company's next earnings report is scheduled for August 5, with consensus EPS expected at $8.98.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}